I believe that we'll see an update to the company website as well as either a letter or quarterly report when the company feels they have something really worthwhile saying. Hopefully they'll gain patents approvals soon or initiate new trials, but until either something like that, or a new partnership occurs, I don't think a report that just says we'll keep on keeping on will be worth anything, let's wait till they have news.

I believe the quarterly will probably come by Mid November so that might be the first time we hear anything, but nothing is certain. The company generally posts results after a permitted extension, but they do file unlike many companies who're forced to move from the OTC to the Pinks.

Gary